In the News
Press Release: New legislation to improve access to essential pediatric and rare disease medications introduced in Parliament
The legislation is the culmination of months of collaborative work led by the RareKids-CAN network and the Child Health Policy Accelerator at The Hospital for Sick Children, with contributions from RareKids-CAN representatives and patient advocates from across the country.
Key Considerations for Rare Diseases in First Nations* Populations in Canada
Many First Nations communities face a disproportionate demand for specialized rare disease care and early identification is essential for timely treatment and life planning.
RareKids-CAN Open Call: Sponsored American Society for Gene & Cell Therapy - Attendance for Pediatric ATMP Clinical Trial Professionals
Apply today to attend the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in May 2026.
